Related Experiment Video
Updated: Oct 27, 2026

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
Histone Lactylation Drives WNK1 Expression to Promote Esophageal Squamous Cell Carcinoma Progression Through Histone
Mingyang Yan1,2, Shaobo Fang2,3, Yanming Song2
1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Abstract:
Esophageal squamous cell carcinoma (ESCC) lacks effective targeted therapies, and how metabolic reprogramming drives oncogenic signaling remains poorly defined. Here, we identify histone H3 lysine 23 lactylation (H3K23la) as a key epigenetic mediator linking lactate accumulation to tumor progression. H3K23la is upregulated in ESCC and correlates with poor prognosis. Mechanistically, H3K23la promotes WNK lysine deficient protein kinase 1 (WNK1) transcription, which increases histone H3 Ser10 phosphorylation (p-H3S10) and enhances AKT transcription, thereby driving PI3K-AKT signaling. This defines a lactate-H3K23la-WNK1-p-H3S10-AKT axis connecting metabolism to oncogenic signaling. Importantly, pharmacological inhibition of WNK1 by CD03017 disrupts this pathway and suppresses tumor growth in vitro and in patient-derived xenograft (PDX) models. In conclusion, our findings define a metabolic-epigenetic-signaling axis in ESCC and establish WNK1 as a potential therapeutic target downstream of histone lactylation.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Canonical Wnt Signaling Pathway
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Histone Variants at the Centromere
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
X-chromosome...
